Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor Dr Muzaale and colleagues1 reported the estimated lifetime risk of end-stage renal disease (ESRD) in donors as 0.9% compared with 0.14% in healthy nondonors and 3.26% in unscreened nondonors (general population), an 8-fold higher cumulative incidence of ESRD in donors compared with healthy nondonor controls. These data are important for discussions with prospective donors, especially donors of African American descent who have the highest relative risk.
Ross LF, Thistlethwaite JR. Outcomes After Kidney Donation. JAMA. 2014;312(1):94. doi:10.1001/jama.2014.6111
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: